SCHEMBL8693236

SCHEMBL8693236

CCCCC(CCCC)NC=O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 5/20 0.54
ADH1A P07327 5/20 0.54
ADH1C P00326 4/20 0.54
ADH7 P40394 4/20 0.54
ADH4 P08319 2/20 0.54
TSHR P16473 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
EPHX1 P07099 2/20 0.41
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
SLC15A1 P46059 1/20 0.35
PLA2G2C Q5R387 2/20 0.35
DNM1 Q05193 1/20 0.35
FDPS P14324 1/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CTSK P43235 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28824011 0.95 ADH1B (0.50) ADH1BADH1AADH1CADH7ADH4
SCHEMBL11435239 0.93 ADH1B (0.64) ADH1BADH1AADH1CADH7ADH4
SCHEMBL11110933 0.93 ADH1B (0.64) ADH1BADH1AADH1CADH7ADH4
SCHEMBL11450788 0.93 ADH1B (0.63) ADH1BADH1AADH1CADH7ADH4
SCHEMBL11111750 0.91 ADH1B (0.67) ADH1BADH1AADH1CADH7ADH4
SCHEMBL18558683 0.91 ADH1B (0.67) ADH1BADH1AADH1CADH7ADH4
SCHEMBL25693408 0.91 ADH1B (0.67) ADH1BADH1AADH1CADH7ADH4
SCHEMBL8626813 0.91 ADH1B (0.50) ADH1BADH1AADH1CADH7ADH4
SCHEMBL20835080 0.91 ADH1B (0.67) ADH1BADH1AADH1CADH7ADH4
SCHEMBL27449319 0.89 ADH1B (0.46) ADH1BADH1AADH1CADH7ADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560267-B1 Isosteric antiherpes peptide derivatives BOEHRINGER INGELHEIM CA LTD (CA) 1998-08-19 EP claimed
EP-0767671-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1997-04-16 EP claimed
US-5574015-A Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1996-11-12 US claimed
WO-1994025046-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-11-10 WO claimed
WO-1993018056-A1 ISOSTERIC ANTIHERPES PEPTIDE DERIVATIVES BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-16 WO claimed
EP-0560267-A1 Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed
US-7241785-B2 Five-membered heterocyclic alkanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-07-10 US disclosed
US-5846941-A Isosteric antiherpes peptide derivatives II BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1998-12-08 US disclosed
EP-0560267-B1 Isosteric antiherpes peptide derivatives BOEHRINGER INGELHEIM CA LTD (CA) 1998-08-19 EP disclosed
EP-0767671-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1997-04-16 EP disclosed
US-5574015-A Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1996-11-12 US disclosed
WO-1994025046-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-11-10 WO disclosed
WO-1993018056-A1 ISOSTERIC ANTIHERPES PEPTIDE DERIVATIVES BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-16 WO disclosed
EP-0560267-A1 Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP disclosed
US-4217111-A REDUCING OCTANE REQUIREMENT CHEVRON RESEARCH COMPANY (US) 1980-08-12 US disclosed